Skip to search.
 TSX Down 1.00% TSX Ventures Down 1.17%

OncoGenex Pharmaceuticals, Inc. (OGXI)

-NasdaqCM
2.45 Down 0.14(5.41%) 4:00PM EST
Add to Portfolio
Prev Close:2.59
Open:2.59
Bid:2.44 x 1600
Ask:2.45 x 1700
1y Target Est:6.85
Beta:0.6
Earnings Date:Mar 9 - Mar 13 (Est.)
Day's Range:2.37 - 2.59
52wk Range:1.92 - 14.25
Volume:350,774
Avg Vol (3m):321,275
Market Cap:52.14M
P/E (ttm):N/A
EPS (ttm):-1.66
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
OGXIDown 5.41%52.14M
BMYDown 1.41%108.24B
CELGDown 2.22%94.49B
PFEDown 1.45%208.20B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):1.83
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.45
Quarterly EPS Est (Dec-14) :-0.30
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

OncoGenex Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapies that address treatment resistance in cancer patients. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback